Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

This publication has 15 references indexed in Scilit:

• Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival
  Blood, 2002
• Primary immunodeficiency diseases: an experimental model for molecular medicine
  The Lancet, 2001
• Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency
  Cell, 2001
• Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
  Blood, 2001
• Thymic Function after Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency
  New England Journal of Medicine, 2000
• Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell–depleted bone marrow transplantationA retrospective European survey from the European Group for Bone Marrow Transplantation and the European Society for Immunodeficiency
  The Journal of Pediatrics, 1999
• Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency
  New England Journal of Medicine, 1999
• European experience of bone-marrow transplantation for severe combined immunodeficiency
  The Lancet, 1990
• BONE-MARROW TRANSPLANTATION FOR IMMUNODEFICIENCIES AND OSTEOPETROSIS: EUROPEAN SURVEY, 1968-1985
  The Lancet, 1986
• CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S
  Transplantation, 1974